I find myself wanting to buy more OPTI:Optibiotix every time it dips below 65p. I can't stand the idea of newbies coming in at a lower price than I paid, and it relieves some of the misery of a drop when I know I'm reducing the average price.
I've been really pleased with TLOU:Tlou Energy and it's done very well for me, but after the recent rapid rise and with a long way to go before being a profitable venture, I decided to take my £828.15 (59.3%) profit and re-invest the proceeds in OPTI:Optibiotix at these ridiculous prices.
I've also been bothered for 2 years by one of my biggest dog shares LOOK:Lookers. Sentiment in the auto industry is going nowhere, and despite this company being very under-valued, I'm just fed up and have wanted out for ages. I was concerned about the effect of my loss on performance, however today gave me an opportunity to sell without impacting performance. I sold them for a £855.34 (40.9%) loss but liberated £1,212 to spend on OPTI:Optibiotix which I believe has a far better chance of making back my loss than LOOK:Lookers has. The loss was only really £769.21 as I had £86.13 dividends over the 2 years and selling TLOU:Tlou Energy cancelled that out.
So, in my share account I bought 1,921 OPTI:Optibiotix shares at 63.8p costing £1,237.55 and bringing down my weighted average to 64.88p.
In my ISA I bought 3,442 shares, also costing 63.8p (a total bargain!) for £2,207.95. This brought the weighted average down to 69.18p which is great given it used to be about 85p!
My OPTI:Optibiotix holding has now increased to 51,897 shares costing £35,021.28 at a weighted average of 67.48p. This is 49.1% of my entire portfolio cost.
I know the general rule is no more than 10% in one company, but everything I see about OPTI:Optibiotix is so exciting that I'm convinced it's heading for greatness.
The catalyst for today's purchase was news that OPTI:Optibiotix will be co-exhibiting at Probiota with DSM in February. This is one of the long-running joint ventures that's been off the radar for ages, but the sort of partnership that could be massive for OPTI:Optibiotix and be the catalyst for spinning off SweetBiotix as a separate company.
Although TLOU:Tlou Energy did go up some more today, so did OPTI:Optibiotix, so the bid price is already more than I paid.
Each 1p rise in OPTI:Optibiotix will now be worth £518.97, and with over 50,000 shares I should get a decent slice of both SBTX:SkinBioTherapeutics and Sweetbiotix, although my most recent purchases are probably too late to qualify for SBTX:SkinBioTherapeutics.
I'm feeling very happy as 2018 starts off in what promises to be a game-changing year for OPTI:Optibiotix.
No comments:
Post a Comment